New knee injection aims to tackle arthritis pain and bone loss

NCT ID NCT03727022

Completed Disease control Sponsor: Biosplice Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested the safety of an experimental drug called SM04690, given as two injections into the knee about six months apart, for people with moderate to severe knee osteoarthritis pain. The main goal was to see if the injections were safe and how they affected bone density in the knee. Over 100 participants were randomly assigned to receive either the drug or a placebo injection and were followed for up to two years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Phoenix, Arizona, 85018, United States
Research Site

Phoenix, Arizona, 85053, United States
Research Site

Canoga Park, California, 91303, United States
Research Site

Carmichael, California, 95628, United States
Research Site

La Mesa, California, 91941, United States
Research Site

Edgewater, Florida, 32132, United States
Research Site

Miami, Florida, 33143, United States
Research Site

Woodstock, Georgia, 30189, United States
Research Site

Kansas City, Missouri, 64114, United States
Research Site

Albuquerque, New Mexico, 87102, United States
Research Site

Cincinnati, Ohio, 45246, United States
Research Site

Charleston, South Carolina, 29406, United States
Research Site

San Angelo, Texas, 76904, United States

Conditions

Explore the condition pages connected to this study.

KNEE OSTEOARTHRITIS